Agenda

Focus on fertility care is increasing, not just within our industry but also culturally, economically, and politically.

The implications for women's healthcare and lives globally are significant. As declining birth rates reshape policy conversations, with countries including China, South Korea, and Japan responding through targeted initiatives, to address falling fertility rates and fertility preservation and reproductive planning moving increasingly into mainstream conversation. This session explores what's driving the gap between demand and access, the role of AI and digital health in diagnostics and treatment, and how women are engaging with fertility treatments in the age of consumerisation of health.

Speakers will examine innovation across drug development, diagnostics, and medical devices, and how employers, policymakers, and healthcare organizations can better support fertility care access. EMD Serono will share how the company is working to expand affordability through pricing initiatives — including Most Favored Nation pricing — and partnerships with the U.S. government, alongside broader efforts to advance access to fertility treatment worldwide.

Attendees will leave with a clearer view of how demographic trends, innovation, and policy are converging to shape fertility care for women globally.